News & Updates

Show Multimedia Only

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

25 Feb 2024

Prophylactic apixaban appears to effectively reduce the risk of venous thromboembolism (VTE) for patients undergoing open surgery for gynaecologic malignancies and should be considered the standard of care for VTE prophylaxis in this population, according to a retrospective study.

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

25 Feb 2024

Ertapenem infusion beneficial in hidradenitis suppurativa

24 Feb 2024

Treatment with intravenous ertapenem yields improvements in the clinical and inflammatory markers of hidradenitis suppurativa (HS), according to a retrospective study.

Ertapenem infusion beneficial in hidradenitis suppurativa

24 Feb 2024

LDL-C–lowering therapies bear a small risk of haemorrhagic stroke

24 Feb 2024 by

Medications that regulate low‐density lipoprotein‐cholesterol (LDL‐C) levels appear to contribute to a slight increase in the risk of haemorrhagic stroke events, according to a meta-analysis.

LDL-C–lowering therapies bear a small risk of haemorrhagic stroke

24 Feb 2024

Pembrolizumab delivers long-term survival benefits in advanced esophageal cancer

24 Feb 2024 by

First-line pembrolizumab (pembro) plus chemotherapy (chemo) in patients with untreated advanced esophageal cancer demonstrates robust efficacy after 5 years, with no new safety concerns, when compared with placebo plus chemo, according to a study presented at ASCO GI 2024.

Pembrolizumab delivers long-term survival benefits in advanced esophageal cancer

24 Feb 2024

Methylnaltrexone proves safety in paediatric oncology patients with constipation

24 Feb 2024

Subcutaneous methylnaltrexone is safe to use in children with cancer who have opioid-induced constipation, suggest the results of a study. In addition, this agent stimulates bowel movements in more than a third of paediatric patients.

Methylnaltrexone proves safety in paediatric oncology patients with constipation

24 Feb 2024

Abatacept may mitigate rheumatoid arthritis development in at-risk individuals

23 Feb 2024 by

The use of abatacept in adults at high risk of rheumatoid arthritis helps protect against disease onset, as shown in the phase IIB APIPPRA study.

Abatacept may mitigate rheumatoid arthritis development in at-risk individuals

23 Feb 2024

Patients on anticancer therapeutic agents may develop carpal tunnel syndrome

23 Feb 2024

Carpal tunnel syndrome (CTS) is not uncommon in patients being treated with anticancer therapeutic agents, reports a study. Electrodiagnostic (EDX) studies and ultrasound (US) are necessary in the diagnostic assessment of these individuals.

Patients on anticancer therapeutic agents may develop carpal tunnel syndrome

23 Feb 2024

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

23 Feb 2024 by

In the phase II UNITY study, foetuses and neonates whose mums were receiving nipocalimab for early-onset (≤24 weeks gestational age [GA]) severe haemolytic disease of the foetus and newborn (EOS-HDFN) had minimal exposure to the drug.

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

23 Feb 2024

Low-dose oral midazolam not linked to improved patient satisfaction after surgery

23 Feb 2024

Premedication with low-dose oral midazolam in older patients undergoing a surgical procedure falls short of improving perioperative patient satisfaction, according to a study.

Low-dose oral midazolam not linked to improved patient satisfaction after surgery

23 Feb 2024

Acetylcholinesterase inhibitors may have potential protective effect against AMD

22 Feb 2024

In the treatment of individuals with Alzheimer’s disease, acetylcholinesterase inhibitors (AChEIs) appear to confer a small reduction in the risk of age-related macular degeneration (AMD), as shown in a study.

Acetylcholinesterase inhibitors may have potential protective effect against AMD

22 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

Apixaban recommended for blood clot prevention in gynaecologic cancer surgery

Ertapenem infusion beneficial in hidradenitis suppurativa

Ertapenem infusion beneficial in hidradenitis suppurativa

LDL-C–lowering therapies bear a small risk of haemorrhagic stroke

LDL-C–lowering therapies bear a small risk of haemorrhagic stroke

Pembrolizumab delivers long-term survival benefits in advanced esophageal cancer

Pembrolizumab delivers long-term survival benefits in advanced esophageal cancer

Methylnaltrexone proves safety in paediatric oncology patients with constipation

Methylnaltrexone proves safety in paediatric oncology patients with constipation

Abatacept may mitigate rheumatoid arthritis development in at-risk individuals

Abatacept may mitigate rheumatoid arthritis development in at-risk individuals

Patients on anticancer therapeutic agents may develop carpal tunnel syndrome

Patients on anticancer therapeutic agents may develop carpal tunnel syndrome

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

Low-dose oral midazolam not linked to improved patient satisfaction after surgery

Low-dose oral midazolam not linked to improved patient satisfaction after surgery

Acetylcholinesterase inhibitors may have potential protective effect against AMD

Acetylcholinesterase inhibitors may have potential protective effect against AMD